Literature DB >> 16506043

Biological monitoring of exposure to 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate.

C J Sennbro1, C H Lindh, C Mattsson, B A G Jönsson, H Tinnerberg.   

Abstract

OBJECTIVES: Biological monitoring of occupational sensitizers, such as 1,5-naphthalene diisocyanate (NDI) and 4,4'-methylenediphenyl diisocyanate (MDI) is of high importance. In this study, 1,5-naphthalenediamine (NDA) and 4,4'-methylenedianiline (MDA) in hydrolysed urine and plasma were evaluated as biomarkers of exposure to NDI and MDI, respectively.
METHODS: The air exposure to NDI and MDI was monitored for 30 exposed workers at four different plants. In parallel, urinary as well as blood plasma samples were collected. Biomarker levels were determined in hydrolysed urine and plasma by means of gas chromatography-mass spectrometry.
RESULTS: Air exposure to both MDI and NDI was correlated to their corresponding urinary and plasma biomarkers. The correlation coefficients for the associations between air and biomarker levels were in the range of 0.51-0.65 and 0.53-0.96 for MDI and NDI, respectively. For NDI, but not for MDI, the significance and correlation coefficients were increased by adjusting the urinary biomarker levels for creatinine content or density.
CONCLUSIONS: Biomarker and air levels of MDI and NDI were correlated, but there was a large individual variation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16506043     DOI: 10.1007/s00420-006-0096-5

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  24 in total

1.  Respiratory diseases caused by occupational exposure to 1,5-naphthalene-diisocyanate (NDI): Results of workplace-related challenge tests and antibody analyses.

Authors:  X Baur; Z Chen; B Marczynski
Journal:  Am J Ind Med       Date:  2001-04       Impact factor: 2.214

2.  Development, validation and characterization of an analytical method for the quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4- and 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate.

Authors:  Carl Johan Sennbro; Christian H Lindh; Håkan Tinnerberg; Cecilia Gustavsson; Margareta Littorin; Hans Welinder; Bo A G Jönsson
Journal:  Biomarkers       Date:  2003 May-Aug       Impact factor: 2.658

3.  Determination of airborne methyl isocyanate as dibutylamine or 1-(2-methoxyphenyl)piperazine derivatives by liquid and gas chromatography.

Authors:  M L Henriks-Eckerman; J Välimaa; C Rosenberg
Journal:  Analyst       Date:  2000-11       Impact factor: 4.616

4.  Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate.

Authors:  R Merget; B Marczynski; Z Chen; K Remberger; M Raulf-Heimsoth; P O Willrot; X Baur
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

5.  A survey of airborne isocyanate exposure in 13 Swedish polyurethane industries.

Authors:  Carl J Sennbro; Christian H Lindh; Anders Ostin; Hans Welinder; Bo A G Jönsson; Håkan Tinnerberg
Journal:  Ann Occup Hyg       Date:  2004-07-07

6.  Biological monitoring of isocyanates and related amines. III. Test chamber exposure of humans to toluene diisocyanate.

Authors:  G Skarping; T Brorson; C Sangö
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

7.  Hypersensitivity pneumonitis-like reaction among workers exposed to diphenylmethane [correction to piphenylmethane] diisocyanate (MDI).

Authors:  O Vandenplas; J L Malo; M Dugas; A Cartier; A Desjardins; J Lévesque; M A Shaughnessy; L C Grammer
Journal:  Am Rev Respir Dis       Date:  1993-02

8.  Determination of 4,4'-methylenedianiline in hydrolysed human urine by micro liquid chromatography with ultraviolet detection.

Authors:  P Brunmark; P Persson; G Skarping
Journal:  J Chromatogr       Date:  1992-09-02

9.  Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,4'-methylenediphenyl diisocyanate.

Authors:  O Sepai; D Henschler; G Sabbioni
Journal:  Carcinogenesis       Date:  1995-10       Impact factor: 4.944

10.  Biomonitoring of 4,4'-methylene dianiline by measurement in hydrolysed urine and plasma after epicutaneous exposure in humans.

Authors:  P Brunmark; M Bruze; S Skerfving; G Skarping
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

View more
  6 in total

1.  Urine 1,6-hexamethylene diamine (HDA) levels among workers exposed to 1,6-hexamethylene diisocyanate (HDI).

Authors:  Linda G T Gaines; Kenneth W Fent; Sheila L Flack; Jennifer M Thomasen; Louise M Ball; David B Richardson; Kai Ding; Stephen G Whittaker; Leena A Nylander-French
Journal:  Ann Occup Hyg       Date:  2010-06-07

Review 2.  Developments in laboratory diagnostics for isocyanate asthma.

Authors:  Adam V Wisnewski
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-04

3.  A murine monoclonal antibody with broad specificity for occupationally relevant diisocyanates.

Authors:  Angela R Lemons; Paul D Siegel; Morgen Mhike; Brandon F Law; Justin M Hettick; Toni A Bledsoe; Ajay P Nayak; Donald H Beezhold; Brett J Green
Journal:  J Occup Environ Hyg       Date:  2014       Impact factor: 2.155

4.  Biomarkers of exposure in Monday morning urine samples as a long-term measure of exposure to aromatic diisocyanates.

Authors:  Håkan Tinnerberg; Karin Broberg; Christian H Lindh; Bo A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2013-04-05       Impact factor: 3.015

5.  Quantitative plasma biomarker analysis in HDI exposure assessment.

Authors:  Sheila L Flack; Kenneth W Fent; Linda G Trelles Gaines; Jennifer M Thomasen; Steve Whittaker; Louise M Ball; Leena A Nylander-French
Journal:  Ann Occup Hyg       Date:  2009-10-04

6.  Biomonitoring for Occupational Exposure to Diisocyanates: A Systematic Review.

Authors:  Bernice Scholten; Laura Kenny; Radu-Corneliu Duca; Anjoeka Pronk; Tiina Santonen; Karen S Galea; Miranda Loh; Katriina Huumonen; Anne Sleeuwenhoek; Matteo Creta; Lode Godderis; Kate Jones
Journal:  Ann Work Expo Health       Date:  2020-07-01       Impact factor: 2.179

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.